Concepedia

Lisa Tan

LT

Statistics

Publications

7

Citations

866

H-Index

7

Active since

2019

Affiliations

University of California, San Francisco(Current)

Dana-Farber Cancer Institute

Chan Zuckerberg Initiative (United States)

UCSF Helen Diller Family Comprehensive Cancer Center

Howard Hughes Medical Institute

Lisa Tan is an author at University of California, San Francisco specializing in cancer metabolism, tumor biology, and drug resistance.

Top concepts

Publications per year

2019–2024

7

Publications

7

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing

Ashley Maynard, Caroline E. McCoach, Julia Rotow et al. · Cell · 2020 · 666 citations · Full text

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

Deborah R. Caswell, Philippe Gui, Manasi K. Mayekar et al. · Nature Genetics · 2023 · 76 citations · Full text

Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study

Collin M. Blakely, Anatoly Urisman, Matthew A. Gubens et al. · Journal of Clinical Oncology · 2024 · 44 citations · Full text

Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling

Sebastijan Hobor, Maise Al Bakir, Crispin T. Hiley et al. · Nature Communications · 2024 · 38 citations · Full text

Targeted cancer therapy induces APOBEC fuelling the evolution of drug resistance

Manasi K. Mayekar, Deborah R. Caswell, Natalie I. Vokes et al. · 2020 · 19 citations · Full text

, , +20

1–5 of 7